Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen

Frédéric Baron^*, Myriam Labopin, Annalisa Ruggeri, Jan J Cornelissen, Ellen Meijer, Henrik Sengeloev, Dietger Niederwieser, Marco R De Groot, Harry C Schouten, Noel Milpied, Didier Blaise, Bipin N Savani, Eliane Gluckman, Mohamad Mohty, Arnon Nagler

^*Corresponding author for this work